During a live event, Robert Orlowski, MD, PhD, and participants discussed how access barriers, disease tempo, and bridging choices shape CAR T referral for a patient with early relapsed multiple ...
Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of cytisinicline treatment, with quit rates rising through the year ...
A cross-sectional survey of 345 licensed Saudi community pharmacists mapped self-reported medication-adherence strategies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results